This list doesn’t include all possible ... is a rare but serious side effect possible with any inhaler, including Incruse Ellipta. But it’s not clear whether this side effect occurred in ...

CMS is expected to announce in early 2025 the list of up to 15 Medicare Part D drugs that will be subject to price negotiations in 2025, with negotiated prices expected to be implemented in 2027.

Keep this leaflet with the medicine. You may need to read it again. TRELEGY ELLIPTA is a dry powder inhaler. When you breathe in using the inhaler, the medicine is deposited into the lungs.

Doctors are to be taught to avoid giving asthma patients traditional inhalers if possible because of the greenhouse gases ...

The U.S. Centers for Medicare & Medicaid Services released on Wednesday a preliminary list of 101 generic drugs that would be ...

Patients with asthma and COPD routinely switch from pressurized metered-dose inhalers to dry powder inhalers and vice versa.

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.

The pharmaceutical company Qnovia announced that the FDA approved its experimental nicotine inhaler for trial in the U.S. The ...

Learn about the Biden administration's plan to offer Medicare pilot program for affordable generic drugs, including common ...

Doctors could be taught to limit the use of traditional asthma inhalers due to their environmental impact. This initiative, led by the University of Glasgow and coordinated by the European ...